Efficacy of Bosentan in Digital Ischemic Ulcers

被引：12
|
作者：
Todoli Parra, Jose A. [1 ]
Miralles Hernandez, Manuel [2 ]
Arrebola Lopez, Manuel A. [2 ]
机构：
[1] Hosp Univ La Fe, Dept Internal Med, Valencia 46009, Spain
[2] Hosp Univ La Fe, Angiol & Vasc Surg Dept, Valencia 46009, Spain
来源：
ANNALS OF VASCULAR SURGERY | 2010年 / 24卷 / 05期
关键词：
BUERGERS-DISEASE; THROMBOANGIITIS;
D O I：
10.1016/j.avsg.2010.03.011
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Thromboangiitis obliterans (also known as Buerger's disease) is an inflammatory vascular disorder that affects small and medium-sized arteries and veins in the extremities. There is no specific treatment and the only effective intervention is absolute cessation of tobacco use. Endothelial dysfunction appears to be of relevance to this condition and a report has even found that high serum levels of endothelin correlate with the presence of necrosis. We report two cases of digital necrosis showing a very satisfactory response to treatment with bosentan, a dual endothelin receptor antagonist.
引用
收藏
页码：690.e1 / 690.e4
页数：4
相关论文
共 50 条
  • [11] Long-term efficacy and safety of bosentan in the treatment of ischemic digital ulcers due to severe Raynaud's phenomenon in patients with systemic sclerosis
    Alegre-Sancho, JJ
    Fernández-Llanio, N
    Hortal-Alonso, R
    Muñoz-Gil, S
    Pareja-Lázaro, MA
    Román-Ivorra, JA
    Abad-Franch, L
    Alcañiz-Escandell, C
    Chalmeta-Verdejo, C
    Fernández-Carballido, C
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 287 - 287
  • [12] BOSENTAN TREATMENT OF DIGITAL ULCERS RELATED TO SYSTEMIC SCLEROSIS
    Giancotti, S.
    Cimino, R.
    Pintaudi, C.
    Mazzuca, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S75 - S75
  • [13] Bosentan as a rescue therapy in scleroderma refractory digital ulcers
    Chamaillard, Melanie
    Heliot-Hosten, Isabelle
    Constans, Joel
    Taieb, Alain
    ARCHIVES OF DERMATOLOGY, 2007, 143 (01) : 125 - 126
  • [14] Digital ulcers in Systemic Sclerosis:: Effectiveness by treatment with Bosentan
    Lefebvre, PGDP
    Rubio, SR
    Expósito, MV
    Bonilla, GR
    Mendoza, AZ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 305 - 305
  • [15] RAPID RESPONSE OF DIGITAL ULCERS TO BOSENTAN IN SYSTEMIC SCLEROSIS
    Athanassiou, P.
    Kostoglou-Athanassiou, I.
    Basdragianni, D.
    Papadaki, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S114 - S114
  • [16] SUCCESSFUL TREATMENT OF SYSTEMIC SCLEROSIS DIGITAL ULCERS WITH BOSENTAN
    Athanassiou, P.
    Kalaycheva, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S114 - S114
  • [17] Bosentan treatment of digital ulcers related to autoimmune disorders
    Cantisani, Carmen
    Mattozzi, Carlo
    Giancristoforo, Simona
    D'Epiro, Sara
    Richetta, Antonio G.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 750 - 755
  • [18] LONG-TERM EFFICACY AND SAFETY OF BOSENTAN IN PATIENTS WITH DIGITAL ULCERS RELATED TO SYSTEMIC SCLEROSIS
    Cristina, N.
    Groseanu, L.
    Berghea, F.
    Balanescu, A.
    Bojinca, V.
    Mazilu, D.
    Daia, S.
    Opris-Belinski, D.
    Saulescu, I.
    Constantinescu, L.
    Abobului, M.
    Borangiu, A.
    Negru, M. M.
    Cobilinschi, C.
    Predeteanu, D.
    Duna, M.
    Ionescu, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 164 - 164
  • [19] BOSENTAN AS AN EFFECTIVE TREATMENT FOR DIGITAL ULCERS OF DIFFERENT AETIOLOGIES
    Dias, C.
    Dias, G.
    Faria, T.
    Martins, J.
    Brazao, M. L.
    RHEUMATOLOGY, 2012, 51 : 100 - 100
  • [20] DIGITAL ULCERS IN SSc: TREATMENT OF THREE CASES WITH BOSENTAN
    Martins, S.
    Gil, C.
    Carvalho, M.
    RHEUMATOLOGY, 2012, 51 : 78 - 78
12345